Article Listing - Stock Commentary - New York week to May 28, 2007

APPOINTMENTS AT DU PONT MERCK

25 May 1992

- Du Pont Merck Pharmac-eutical Co: Pieter Timmermans named vice president of drug discovery. He is replacing Robert Taber,...

FUJISAWA LAUNCHES NOVACT M

25 May 1992

- Fujisawa Pharmaceutical has announced the launch of Novact M (coagulation factor IX). Originally developed by the Chemo-Sero-Therapeutic Research...

CELLTECH AND BAYER IN SEPSIS DEAL

25 May 1992

- Celltech has formulated a deal with Bayer of Germany that should generate

PFIZER'S DIFLUCAN LAUNCHED IN NIGERIA

25 May 1992

- Pfizer Products has launched its new anti-fungal agent Diflucan (fluconazole) in Nigeria. Its clinical efficacy and saftey has been...

MARS STUDY REVEALS NEW REGRESSION DATA

25 May 1992

New data has been presented by Merck Sharp & Dohme to support the growing body of research showing that atherosclerosis...

US DRUG FIRMS' PUERTO RICO TAX CREDITS

25 May 1992

The average amount of credits per employee for drug firms operating in Puerto Rico is $70,788, against $10,593 per employee...

US SELF-MEDICATION STUDIED

25 May 1992

When Americans have colds, headaches and other common ailments, they now use over-the-counter medicines 38% of the time, compared with...

WHA: CONSUMERISTS & ETHICAL CRITERIA

25 May 1992

Ethical Criteria for Medicinal Drug Promotion attracted heated debate and lobbying during this year's World Health Assembly, the 45th, (Marketletter...

SNIP DRUGS, ECONOMY AND SOCIAL ENVIRONMENT CONF

25 May 1992

The French pharmaceutical manufacturers' association, SNIP, has organized a conference under the title Drugs, Economy and Social Environ-ment, New Approaches,...

CIBA-GEIGY CITES "SINISTER TENDENCY"

25 May 1992

Alex Krauer, chairman of Swiss pharmaceutical and chemical concern, Ciba-Geigy, referred in his address at the company's annual general meeting...

Showing 94031-94040 of 95579 articles